Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.
about
Richter transformation of CLL.Richter's transformation to diffuse large B-cell lymphoma: a retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group.Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.A unique case of concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and lymphomatoid papulosis in the same biopsy.Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemia.Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.An integrated Bayesian analysis of LOH and copy number data.Detection of Hodgkin Transformation in a Case of Chronic Lymphocytic Leukemia by PET/CTDiffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patientsClonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.Chest Wall Swelling, A Rare Presentation of Richter's Transformation.Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter's syndrome.A Rare Cause of Cavitary Lesion in the Lung: Richter's Transformation.State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.Molecular pathogenesis of chronic lymphocytic leukemia.Waldenstrom's macroglobulinemia associated with Hodgkin's lymphoma: a case reportGenetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndromeIntrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance.Richter Transformation of Chronic Lymphocytic Leukemia: A Review of Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography and Molecular DiagnosticsHow we treat Richter syndrome.A systematic review on Richter syndrome: what is the published evidence?Predictive markers and driving factors behind Richter syndrome development.Salvage therapy for relapsed chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Cutaneous Richter syndrome: a better place to transform?Risk factors for Richter syndrome in chronic lymphocytic leukemia.Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia.XV. Clinical aspects of transformed lymphoma.An update for Richter syndrome - new directions and developments.Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literatureDiagnostic dilemmas of high-grade transformation (Richter's syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review.Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma.Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival.Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.Development of diffuse large B-cell lymphoma in a patient with Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms.Richter Syndrome in Chronic Lymphocytic Leukemia.NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
P2860
Q30249283-7A046AA1-ABF9-4CA4-A750-57CFB2552BAFQ30841807-91C5A6AE-1822-4D5F-B9EA-0983F3ABDE77Q33414468-52BF461D-D34C-4778-A657-7118CA638FE5Q33417548-DCDB676A-A541-4D84-AA0B-455D54ACADD0Q33418623-C8ACF25E-B8FA-464A-B986-723E41ACA639Q33421376-CAF5A48A-21D5-4BAB-A256-AEA5926A8780Q33494799-840B89E0-ACAD-47B6-B06B-B98C1EE93FC8Q33605291-803AE4BB-C1C0-4843-9B35-1E8B21F36AF2Q33795848-766ABFE0-1969-4D55-A89F-E4D841C90B62Q33903379-442F5E42-5C78-4EE5-ACB6-782EFE2C03BEQ33930452-6EFEF857-5F2C-42F2-B7B1-74C9A2121491Q34406844-61AE4F7D-E214-46EC-8A77-E88119A2AFB1Q35086905-D8BA7471-2B7E-4536-98F6-1C6F730D5039Q35163230-CD31BC80-B5CD-4392-BA63-D14D1CD84639Q35860550-4EDD6AF1-08A3-4D3B-BDF3-C48F2CCCBC4FQ36290321-E49298E5-ED31-4419-9017-3A6722297F33Q36325566-391BD4FA-2032-4B9C-A3B0-73618A45183FQ37246532-6C077461-874D-4E46-998F-3F4602E04C58Q37588785-C851D9DD-DB34-48A1-96C0-19D4FBE731ECQ37632830-CB7988A4-3781-40E6-B404-D1C98094108AQ37636962-5DB295EC-6F0D-4BBD-98DF-37761713F829Q37676244-8FF907C2-5D82-4DD8-B8E3-FE6A462A65FBQ37854712-9E5E5DC4-5CBD-497E-B378-D3865027DC80Q37865547-F023B5A3-87F1-464F-831D-3E6E2CCD2994Q38088354-9ECEE81F-B152-4526-9668-6352D84AF262Q38220731-AEAEC62F-D86B-405B-B0C9-9545EB357CFAQ38248873-4A6247E7-4668-4F58-BCC6-64D43AE76737Q38263924-314A5990-9FCA-4090-B68D-716AC76DB951Q38421916-C6DB566C-E13F-49CA-9D99-D02E246FCB79Q38524020-669D46F6-4CA5-4075-AD4C-8A3C800D5C72Q38691261-291D2613-6276-49D9-BC6E-91FFAA8D695EQ38719230-5B896C13-0141-4389-8C82-EAE283010584Q38877593-2EAD676C-C881-4164-809E-65DCC5E7662EQ38896306-6CE68A02-4544-4064-8FEC-A20AFFDE7AA8Q38924571-07C13487-BDBB-4023-8581-2B7916A3B210Q38962267-0518B37D-4A68-4732-AA45-4950B5CAD02BQ39025300-7315621F-2A04-42EA-8DF8-C8F7F08A0F69Q39805986-47C35045-291B-4885-B16E-97BF7E41CEB3Q40037434-A49DB2D2-4C6B-4241-B6C3-5E7958511289Q40098409-27E14E0E-3E5B-44B1-8061-7E4254C959DC
P2860
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Biological and clinical risk f ...... formation to Richter syndrome.
@en
Biological and clinical risk f ...... formation to Richter syndrome.
@nl
type
label
Biological and clinical risk f ...... formation to Richter syndrome.
@en
Biological and clinical risk f ...... formation to Richter syndrome.
@nl
prefLabel
Biological and clinical risk f ...... formation to Richter syndrome.
@en
Biological and clinical risk f ...... formation to Richter syndrome.
@nl
P2093
P2860
P50
P1476
Biological and clinical risk f ...... formation to Richter syndrome.
@en
P2093
Annarita Conconi
Antonio Ramponi
Chiara Vendramin
Clara Deambrogi
Corrado Magnani
Davide Rossi
Francesca Maria Rossi
Guido Monga
Michaela Cerri
Monia Lunghi
P2860
P304
P356
10.1111/J.1365-2141.2008.07166.X
P407
P577
2008-05-19T00:00:00Z